Purevdorj B Olkhanud (Purevdorj Olkhanud)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 3

Top Topics

Peritoneal Dialysis

Mesenchymal Stem Cells

Top Venues

Journal for immunotherapy of cancer

Journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

William Becker, Purevdorj B Olkhanud, Noriko Seishima, Paloma A Moreno, Katherine C Goldfarbmuren, Hoyoung M Maeng, David M Moore
Second-generation checkpoint inhibitors and Treg depletion synergize with a mouse cancer vaccine in accordance with tumor microenvironment characterization. Journal for immunotherapy of cancer 12 (7) (2024)
William Becker, Purevdorj B Olkhanud, Noriko Seishima, Paloma A Moreno, Katherine C Goldfarbmuren, Hoyoung M Maeng, David M Moore
Second-generation checkpoint inhibitors and Treg depletion synergize with a mouse cancer vaccine in accordance with tumor microenvironment characterization. Journal for immunotherapy of cancer 12 (7) (2024)
Mahogany Oldham, Anna Conrey, Corinne Pittman, Cameron Fisher, Simone Hargrett, Kamille West, Mary Jackson, Staci Martin, Matthew M Hsieh, Neal Jeffries, Mihailo Kaplarevic, Dachelle Johnson, Purevdorj B Olkhanud, Courtney D Fitzhugh
Computer Algorithm-Based Hydroxyurea Dosing Facilitates Titration to Maximum Tolerated Dose in Sickle Cell Anemia. Journal of clinical pharmacology 61 (1) (2020)